ENDOMET BIOSCIENCES, INC
EndoCyclic Therapeutics
IRVINE, United States · Founded 2019 · $3.0M raised
- Headquarters
- IRVINE, California
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2G
- Website
- endocyclictherapeutics.com
- Total Funding
- $3.0M
- Last Round
- $2.0M GrantApr 2025
- Rounds
- 2
About
Endomet Biosciences (now EndoCyclic Therapeutics) is a biopharmaceutical company developing first-in-class non-hormonal therapeutics and diagnostics for endometriosis and oncology. Its lead program ENDO-205 is a pH-sensitive peptide therapeutic designed to eliminate endometriosis lesions without hormones or systemic toxicity, with FDA IND clearance obtained.
Summary
ENDOMET BIOSCIENCES, INC is a Biotech company based in IRVINE, United States, founded in 2019. It has raised $3.0M in total across 2 rounds, most recently a $2.0M Grant round in Apr 2025. Investors include National Institute of Child Health and Human Development and Small Business Innovation Research.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...